Lymph‐circulating tumor cells show distinct properties to blood‐circulating tumor cells and are efficient metastatic precursors
The leading cause of breast cancer‐associated death is metastasis. In 80% of solid tumors, metastasis via the lymphatic system precedes metastasis via the vascular system. However, the molecular properties of tumor cells as they exit the primary tumor into the afferent lymphatics en route to the sen...
Main Authors: | Sulma I. Mohammed, Odalys Torres‐Luquis, Elwood Walls, Frank Lloyd |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12494 |
Similar Items
-
In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease
by: Mikyung Han, et al.
Published: (2020-10-01) -
Research Progress on Intracranial Lymphatic Circulation and Its Involvement in Disorders
by: Fan Chen, et al.
Published: (2022-03-01) -
Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer
by: Dorothea Sonja Schott, et al.
Published: (2021-03-01) -
Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis
by: Mohammed SI, et al.
Published: (2020-03-01) -
The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
by: Lorena Alexandra Lisencu, et al.
Published: (2021-02-01)